Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Echosens
Age
18–79
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
All groups
* Both gender, 18-79 years old
* Patient able to give written informed consent form
* Patient affiliated to a social security system.
Case group
* Patient with chronic liver disease due to: hepatitis C virus, hepatitis B virus or Alcoholic Liver Disease and liver stiffness ≥ 14 kPa
* Patient with the following examination within 3 months of LSM and SSM: ultrasound examination, blood examination, gastroscopy examination and eventually an hepatic venous pressure gradient examination
Control groups
* Patient with chronic liver disease due to: HCV, HBV or Alcoholic Liver Disease and liver stiffness \< 14 kPa
* Patients without chronic liver disease (Healthy Control subgroup)
You may not be if
Patient unable or unwilling to provide written informed consent.
Antiviral treatment during the two months before inclusion.
Pacemaker or heart defibrillator.
Pregnancy.
Liver transplantation.
BMI\>35 kg/m2.
Serum Transaminases \> 250 IU/L.
History of / or current βblockers treatment of OV.
Presence of ascites.
Previous endoscopic treatment of OV.
Patient with acute alcoholic hepatitis and associated jaundice (generally defined by total bilirubin ≥ 50 µmol/l).
Patient with hepatocellular carcinoma (HCC).
Unable or unwilling to undergo a liver stiffness measurement, a spleen stiffness measurement, an ultrasound examination, a blood examination or a gastroscopy examination.
Clareo Health | Spleen Stiffness Measurement With FibroScan
